
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65576 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Oxprenolol Hydrochloride
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C15H23NO3·HCIColor and Shape:White PowderMolecular weight:405.08009Metoprolol Related Compound C (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C13H19NO3·HClColor and Shape:White PowderMolecular weight:237.13649Carvedilol Related Compound D (4-(Oxiran-2-ylmethoxy)-9H-carbazole)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormula:C15H13NO2Color and Shape:Light Yellow PowderMolecular weight:239.09463Ondansetron
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C18H19N3OColor and Shape:White Off-White PowderMolecular weight:293.15281Brivaracetam Related Compound D ((S)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanoic acid)
CAS:Lactams, nesoiFormula:C11H19NO3Color and Shape:White Off-White Fine PowderMolecular weight:213.13649Carvedilol Related Compound E (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C9H13NO2Color and Shape:Off-White PowderMolecular weight:167.09463Brivaracetam Related Compound C ((R)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS:Lactams, nesoiFormula:C11H20N2O2Color and Shape:White SolidMolecular weight:212.15248Ambrisentan Related Compound E (4,6-Dimethylpyrimidin-2-ol)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C6H8N2OColor and Shape:White Off-White Pale Yellow Crystalline PowderMolecular weight:124.06366Carbamazepine Dione (10,11-dioxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C15H10N2O3Color and Shape:Greenish-Yellow SolidMolecular weight:266.06914Sunitinib Amide (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS:Lactams, nesoiFormula:C16H14FN3O2Color and Shape:Pale Yellow Yellow PowderMolecular weight:299.107Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C16H13N3O2SColor and Shape:Dark Brown PowderMolecular weight:311.07285Aminophenylmorpholinone (4-(4-aminophenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H12N2O2Color and Shape:White Off-White SolidMolecular weight:192.08988Omeprazole Magnesium
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H36MgN6O6S2Color and Shape:White Off-White PowderMolecular weight:712.19882Celecoxib Open Ring (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide)
Sulfonamides, nesoiFormula:C17H15F3N2O3SColor and Shape:Yellow SolidMolecular weight:384.07555Rotigotine Hydrochloride Ethyl Analog ((S)-6-(ethyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H24ClNOSColor and Shape:Beige SolidMolecular weight:337.12671Paroxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClH2OColor and Shape:White Off-White Crystalline PowderMolecular weight:329.14272S-Levetiracetam Hydroxybutyramide Analog ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H16N2O3Color and Shape:White Off-White SolidMolecular weight:188.11609Ondansetron Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Rivaroxaban Amine ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H17N3O4·HClColor and Shape:Off-White SolidMolecular weight:327.09858

